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ABSTRACT 
 
Background 
Aneurysmal subarachnoid hemorrhage (aSAH) affects 30,000 Americans 
each year. Delayed cerebral ischemia caused by cerebral vasospasm is a 
complication that occurs in approximately 30% of aSAH patients and is a major 
cause of morbidity and mortality (Hijdra et al., 1986; Roos et al., 2000). The only 
two established screening methods for vasospasm, transcranial doppler (TCD) 
and CT angiography (CTA), have their own shortcomings (Jan van Gijn, Kerr, & 
Rinkel). Studies have shown that TCD has a 63% sensitivity and 52% specificity 
in detecting vasospasm (Carrera et al., 2009).  Furthermore, TCDs require skilled 
technicians to insonate the cerebral blood vessels thereby explaining why TCDs 
can only be performed once per day.  While CTA is highly specific and sensitive 
in detecting vasospasm, it requires the use of contrast dye which and carries the 
risk of contrast nephropathy. 
 Near Infrared Spectroscopy (NIRS), however, is an FDA approved 
imaging technique that has been used in carotid endarterectomy surgeries to 
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monitor for cerebral ischemia. It is a non-invasive technique and can take 
continuous, 24-hour measurements of cortical oxygenation. Additionally, NIRS 
does not require a trained technician to operate, nor does it confer any risk of 
nephropathy.  Also, it is markedly cheaper than the other methods of detection 
mentioned here because there is no other cost other than the purchase of the 
machine and the disposable sensors. 
  
Results 
Comparison of the left and right brain rSO2 measurements of each patient 
showed no significant differences in oxygen saturation. Comparison of the 
average rSO2 of the 3 patients without vasospasm to the rSO2 measurements of 
the patient with vasospasm at each time point showed that there was a 
significant difference in the mean rSO2 for both the left and right side of the brain 
between these two groups. The left side of brain for the patient with vasospasm 
had a mean difference of 10.58% greater rSO2 (p<0.0001) than the patients 
without vasospasm. Additionally, the right side of the brain for the patient with 
vasospasm had a mean difference of 8.37% greater rSO2 (p = 0.0004) than the 
patients without vasospasm. The absolute NIRS values as well as the TCD 
values were able to detect vasospasm accurately. That is, the TCD velocities 
increased and the NIRS values increased to represent hyperemia after cerebral 
vasoconstriction. The NIRS index, defined as neck rSO2/cerebral rSO2, was not 
able to detect vasospasm in patient 3, but was correct in showing that patients 1, 
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2, and 4 did not have vasospasm. The TCD index, defined as TCDR/TCDL, 
showed that it correctly detected vasospasm in patient 3 while correctly showing 
that patients 1 and 4 did not have vasospasm. A TCD index could not be created 
for patient 2 due to a lack of data.  
 
Conclusion 
 Through this interim assessment of this study and its progress, NIRS 
seems to have some utility in the detection of vasospasm through detecting 
increasing trends in absolute %rSO2 but due to the lack of patient enrollment we 
cannot conclude that just yet. TCD data shows that it can indeed detect 
vasospasm but has technical limitations due to the high level of expertise 
required to capture accurate data. Continued enrollment of patients and their 
age-matched controls are necessary to draw any further conclusions.  
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 1 
INTRODUCTION 
 
Aneurysmal Subarachnoid Hemorrhage 
Aneurysmal subarachnoid hemorrhage (aSAH) is caused by the rupture of 
an intracranial aneurysm and occurs at a rate of 6 to 8 per 100,000 people every 
year (Linn, Rinkel, Algra, & Gijn, 1996). About 1 in 6 patients with aSAH do not 
survive after aneurysmal rupture and those who are able to receive treatment 
have a very poor prognosis as major complications are associated with aSAH 
(Rabinstein, 2013). Even if the bleeding is managed well, aSAH commonly is 
associated with cerebral infarction and resultant neurological deficits. This major 
complication of aSAH, lending to high morbidity and mortality, is delayed cerebral 
ischemia (DCI) due to arterial vasospasm that results in neurologic deficit most 
commonly observed 4 to 10 days post bleed (Hijdra et al., 1986; Roos et al., 
2000). The incidence of vasospasm is around 30% of the aSAH patient 
population (Roos et al., 2000). Typically patients with aSAH will spend the 
majority of their in-patient stay in the intensive care unit (ICU) where they are 
monitored for cerebral vasospasm and neurologic deficits.  
 There are 800,000 strokes per year in the United States and approximate 
87% of these are ischemic strokes caused by clots. The remaining 13% of 
strokes are categorized as hemorrhagic strokes (American Heart Association, 
2012). Aneurysmal subarachnoid hemorrhage is considered to be a type of 
hemorrhagic stroke and it accounts for 5% of all strokes that occur (Bederson et 
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al., 2009a). Although aSAH accounts for a small proportion of strokes every year, 
the costs incurred each year for this type of stroke is disproportionally higher 
compared to other strokes (Taylor et al., 1996).  
 
Figure 1: Lifetime Cost of Strokes. This chart shows the lifetime cost of 
different stroke types incurred per person across all age and sex groups in 1990. 
Costs incurred for people with aSAH are approximately double the cost of the 
cost of all other stroke types (Taylor et al., 1996).  
 
Intracranial Aneurysms 
Intracranial aneurysms are anomalies that occur throughout the life of a 
person. Aneurysms found in aSAH can be either saccular or fusiform in shape 
with the former being more common. As the aneurysm develops over a patient’s 
lifetime it has a 1.3% chance of rupture each year and increases, as it grows 
larger. Intracranial aneurysms have a 90% chance of forming near major branch 
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points in the anterior circulation of the brain and sometimes multiple aneurysms 
can be present (Kuma, Abbas, Fausto, & Mitchell, 2007).  
 
Epidemiology  
The incidence of aSAH in the United States is about 30,000 cases per 
year and the mean age of patients is around 55 years old (Dupont, Wijdicks, 
Lanzino, & Rabinstein, 2010). Seeing as how many patients fall under the mean 
age of 55 years, aSAH generally affects a young population of people 
contributing to the devastating nature of this disease. The incidence of aSAH 
increases with age and women are at a higher risk than men by a factor of 1.6 
(Dupont et al., 2010). As mentioned before, aSAH is a major cause of high 
Figure 2: 
Common 
aneurysm 
locations. 
Shows the 
most common 
sites of 
aneurysms in 
the cerebral 
vasculature 
(Jan van 
Gijin, Kerr, & 
Rinkel).  
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morbidity and mortality and in a 10-year retrospective study of aSAH patients by 
Von Vogelsang et al. it was shown that there was a 28-day case fatality rate of 
19.4%. The study also showed that the mean survival time for patients after 10 
years was 6.8 years for men and 7.2 years for women (Von Vogelsang, 
Wengström, Svensson, & Forsberg, 2012). 
A recent study by Vlak et al. on the lifetime risk factors for aSAH showed 
that there are six predictors of aSAH which are current smoking, a family history 
of the disease, hypertension, excessive alcohol use, regular physical exercise, 
and inversely, hypercholesteremia. Out of these 6 predictors, current smoking, a 
family history of the disease, hypertension, and inversely hypercholesteremia 
were the strongest predictors (Vlak, Rinkel, Greebe, Greving, & Algra, 2013). The 
actual risk that a person has of having an aSAH depends on the combination of 
these risk factors, age, and gender and lifetime risk can range between 0.02% 
and 7.2% (Vlak et al., 2013).  
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Figure 3. Lifetime Risk of aSAH. Lifetime risk percentage of aSAH with respect 
to the four strongest predictors, age, and gender. RLR = remaining lifetime risk, 
RLT = remaining lifetime. Green means ≤ overall incidence for this age and sex 
group, Yellow means 1-2x incidence for this age and sex, Red means > 2x 
incidence for this age and sex. This table shows the percent risk of having an 
aSAH during a persons remaining lifetime according to a persons current age 
and risk factors (Vlak et al., 2013). 
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Meta-analysis has shown that 12.4% (95% confidence interval, 11-14%) of 
patients that suffer from aSAH will not survive long enough to receive treatment 
in a hospital and die suddenly (Huang & Van Gelder, 2002). Once aSAH patients 
have reached the hospital and receive care they face a high mortality and 
morbidity rate due to complications such as delayed cerebral ischemia. Beyond 
that, patients who do well are still at risk for increased risk of mortality attributable 
to cerebrovascular disease. In one study by Korja et al., on the cause-specific 
mortality of survivors of aSAH after 1 year showed that these survivors had about 
double the risk of death in comparison to a matched general population group 
(Korja et al., 2013). Cerebrovascular disease, such as cerebral infarcts or 
hemorrhages, accounted for 28.4% of deaths in the 1-year SAH survivor group 
while cerebrovascular disease only caused 7.7% of all deaths in the general 
matched population (Korja et al., 2013). Risk factors that increased the chance of 
death were age, systolic blood pressure, current smoking, and high cholesterol 
levels. 
In addition to an increased mortality rate for long-term survivors of aSAH 
studies have shown that the health related quality of life warrants attention. In a 
study done by Tjahjadi et al. on the quality of life, questionnaires were circulated 
to aSAH patients, found through retrospective documentation (Tjahjadi et al., 
2012). These questionnaires revealed that aSAH patients had difficulty and 
experienced deterioration in energy levels, cognitive function, social interactions 
and quality of private life, and the need for extra help after aSAH. A staggering 
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86.4% of patients marked that they experienced a “lack of control over their 
bodies.” Some patients also reported that they experienced an impairment of 
orientation and a disruption of social interactions with family, friends, and 
acquaintances. Overall, 66.5% of the patients in this study believed that they 
required more assistance after their aSAH incident (Tjahjadi et al., 2012).  
In another study, Ronne-Engström et al. used the EuroQoL, an instrument 
to measure quality of life, to compare the quality of life in patients at a median of 
12 months post-aSAH to a Swedish reference population. This study concluded 
that aSAH patients generally did worse than the reference population in mobility, 
self-care, usual activities, pain/discomfort, and anxiety/depression (Ronne-
Engström, Enblad, & Lundström, 2013).  
 
Grading Scales 
 There are many grading scales for patients after aneurysmal 
subarachnoid hemorrhage that have been developed, but the most widely-known 
and utilized are the Hunt and Hess grading scale and the Fisher scale (Rosen & 
Macdonald, 2005). The Hunt and Hess scale categorizes the clinical status of a 
patient upon admission into 5 different grades based on the patient’s clinical 
exam. A Hunt and Hess grade of 1 means the patient is asymptomatic or has a 
mild headache and the grade can go all the way up to grade 5 meaning that the 
patient is in a deep coma and shows decerebrate rigidity (Rosen & Macdonald, 
2005).  The Fisher Score assigns a grade from 1 to 4 based on the subarachnoid 
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hemorrhage volume and pattern of blood seen on initial computed tomography 
(CT) scanning (Rosen & Macdonald, 2005). This scale was proposed to predict 
vasospasm after subarachnoid hemorrhage (Fisher, Kistler, & Davis, 1980).  
 
Clinical Features of aSAH 
Patients with aSAH will commonly present with sudden severe headache, 
coined as a thunderclap headache (TCH), which can last up to 1-2 weeks in 
length (Jan van Gijn et al.). Seizures may also occur after rupture of an 
intracranial aneurysm and is considered to be an indicator of hemorrhage (Jan 
van Gijn et al.) Interestingly 15% - 40% of patients with aSAH may have a 
sentinel hemorrhage, or a smaller hemorrhage, before the major hemorrhage 
event and this often leads to misdiagnosis of aSAH and a missed window of 
opportunity for treatment. In the Danish Aneurysm study, 99 patients were found 
to have had warning leaks but were misdiagnosed and after a 2-year follow up, 
43 patients had died (Hauerberg, Andersen, Eskesen, Rosenørn, & Schmidt, 
1991).  
Ruptured aneurysms are often followed by a depressed state of 
consciousness or complete lack of consciousness upon arriving in the 
emergency room. The most probable cause of this change in mental status is an 
increase in intracranial pressure (ICP) or rebleeding (Dupont et al., 2010; Jan 
van Gijn et al.). Additional symptoms that are commonly present along with TCH 
are nausea and/or vomiting, stiff neck, and even focal neurological deficits. 
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However common these symptoms may be during the initial visit to the hospital, 
the variability in the type of headaches that are found in these patients lends to a 
high rate of misdiagnosis of sentinel bleeds, and worse outcomes in these 
patients (Bederson et al., 2009b). Finally the acute phase of aSAH is also 
associated with systemic hypertension, hypoxemia, and electrocardiographic 
changes (Dupont et al., 2010). 
 
Diagnosis of aSAH 
The first diagnostic tool to turn to in a suspected aSAH case is a non-
contrast cranial computed tomography (CT) scan. Cranial CT scans can be both 
highly sensitive and specific in detecting a hemorrhage but as the time elapses 
from the initial onset of bleeding the sensitivity of the CT scan decrease. CT 
scans have 98% to 100% sensitivity during the first 12-hour period after 
aneurysmal rupture. At 24 hours this sensitivity decreases to 93% and after 6 
days it decreases again to 57% to 85% (Edlow, 2005; J van Gijn & van Dongen, 
1982).  This is due to the fact that as time passes the blood in the subarachnoid 
space starts to clear. The CT scan can be used to locate the site of the ruptured 
aneurysm and to estimate the risk of DCI caused by vasospasm by the amount 
of blood burden found in the subarachnoid space (Dupont et al., 2010; Fisher et 
al., 1980).  
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Figure 4. CT Scan of Subarachnoid Bleed. A) CT scan showing a small 
amount of subarchnoid blood in the anterior interhemispheric cistern and lateral 
parts of both Sylvian fissures pointed out by grey arrows. B) CT scan of same 
patient from 2 days later showing progressive hydrocephalus. Blood in the 
cisterns have disappeared. (Jan van Gijn et al.) 
 
A lumbar puncture is performed less often, but is a test that is 
recommended for patients that have suspected aSAH but have normal CT scans. 
A lumbar puncture must be performed after a period of 6 to 12 hours after the 
headache ensues because of the need to distinguish between blood that 
originated from the ruptured aneurysm and blood that may have originated from 
the lumbar puncture itself (Jan van Gijn et al., 2007) . After a period of 6 to 12 
hours has passed, the cerebrospinal fluid (CSF) can be analyzed for 
xanthochromia, which is a yellowish color observed in CSF caused by bilirubin 
(Vermeulen & Van Gijn, 1990). A spectrophotometer can be used to analyze the 
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CSF but an experienced physician will be able to confirm by visual analysis 
(Dupont, Wijdicks, Manno, & Rabinstein, 2008).  
            
Figure 5: Lumbar Puncture. A) Shows a cross-sectional image of the spine with 
a lumbar puncture needle drawing CSF from the subarachnoid space in a lumbar 
puncture (University of Maryland Medical Center, 2009). B) Shows a sample of 
CSF with a yellowish tint due to xanthochromia on the left and a normal sample 
of CSF, which is clear (Williams, 2004).  
 
Magnetic resonance imagining (MRI) or magnetic resonance angiogram 
(MRA) can also be used in diagnosing aSAH but there are many limits that 
prevent these two methods from being practical. MRI is not readily available in 
emergency rooms, it is difficult to have acutely ill patients lie still during the 
imaging, and the cost is very high (Bederson et al., 2009b). The MRA, in addition 
to the problems that apply to the MRI itself, has varying sensitivity for aneurysm 
detection according to the size of the aneurysm. The sensitivity for an aneurysm 
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≥ 5mm is 85% to 100% but at ≤ 5mm the sensitivity will fall to 56% (Atlas, 1997; 
Huston et al., 1994; Wilcock, Jaspan, Holland, Cherryman, & Worthington, 1996).  
 
CT angiography (CTA) has fewer limitations than the MRI and is used 
widely today as a method to detecting aneurysms. It uses an intravenous 
injection of contrast dye and an image is captured as the dye passes through the 
arteries of interest. It has a sensitivity of 77% to 100% and a specificity of 79% to 
100% in detecting aneurysms (Alberico et al., 1995; Korogi et al., 1999; Vieco, 
Shuman, Alsofrom, & Gross, 1995). Finally, catheter angiography is still the gold 
standard procedure in detecting cerebral aneurysms but the invasive nature of 
the procedure make CTA more favorable as both are similarly specific and 
sensitive (Kaufmann et al., 2007). 
 
Figure 6: MRI of an aneurysm (grey arrow) of the left middle cerebral 
artery (MCA). (University of Iowa, n.d.). 
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Surgical treatment in aSAH 
The initial surgical treatment of aSAH involves placement of an external 
ventriculostomy device (EVD).  This allows for the normalization of the high 
intracranial pressures that are seen in patients with Hunt Hess grades III or 
greater.  
Ruptured aneurysms are repaired through either surgical clipping or 
endovascular techniques such as coiling or balloon embolization. Historically, 
surgical clipping was the preferred method but now there is a great move 
towards endovascular therapies due to the results found in the International 
Subarachnoid Aneurysm Trial comparing the two methods (Froehler, 2013). This 
study found that endovascular coiling yielded a 7.4% reduction in risk of death at 
a 1-year time point after surgical intervention for a ruptured intracranial aneurysm 
(Molyneux et al., 2002). However, a number of different factors must be 
considered before deciding which intervention is best. The first factor to consider 
is the morphology of the aneurysm. An aneurysm with a narrow neck, which is 
characterized as <4 mm or a dome-to-neck ratio greater than 2, is a good 
candidate for an endovascular approach because the platinum coils are less 
likely to be dislodged from the aneurysm dome (Froehler, 2013). Another factor 
to consider is the location of the aneurysm and whether or not surgical 
intervention can access the aneurysm with ease. 
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Figure 7: Surgical Treatment of Intracranial Aneurysms. Surgical clipping of 
an aneurysm (Left) vs. endovascular coiling of an aneurysm (Right) (Yale 
Medical Group, n.d.) 
 
Delayed Cerebral Ischemia 
As mentioned before, delayed cerebral ischemia (DCI) is a devastating 
complication that occurs in about 30% of patients with aSAH. Cerebral 
vasospasm is defined as a stenosis or a narrowing of the cerebral arteries and is 
confirmed in patients using CTA imaging. Cerebral vasospasm with confirmation 
by CTA has been shown to statistically occur in 31% to 53% of patients (Frontera 
et al., 2009; Rabinstein et al., 2004). However, not all patients with CTA 
confirmed cerebral vasospasm develop the clinical symptoms of DCI (Vergouwen 
et al., 2010). Clinical features of DCI are described as focal neurological deficits 
like hemiparesis, aphasia, or a depressed level of consciousness and can 
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eventually progress to cerebral infarction and death (Hijdra et al., 1986; 
Rabinstein et al., 2004).  
Prevention and treatment of cerebral vasospasm in aSAH patients 
focuses on improvement of cerebral blood flow, use of a calcium channel blocker 
called nimodipine, and certain endovascular techniques (Dupont et al., 2010). 
Improvement in cerebral blood flow is achieved through the “triple-H” therapy, 
which encompasses the three components hypertension, hypervolemia, and 
hemodilution. Hypertension is brought on by increasing the systolic blood 
pressure with vasopressors and plasma expanders and has been shown in 
multiple studies to mitigate the extent of neurologic deficits in patients 
experiencing cerebral vasospasm (Awad, Carter, Spetzler, Medina, & Williams, 
1987; Darby et al., 1994). The idea behind hypervolemia and hemodilution, which 
is a controlled decrease in hematocrit, is that by lowering blood viscosity one 
could increase cerebral blood flow (Dupont et al., 2010). However, this can be 
seen as paradoxical because a decrease in hematocrit also decreases the 
oxygen carrying capacity of the blood (Ekelund et al., 2002). It must be noted that 
the “triple H” therapy needs more in-depth study into its efficacy as well. The 
complications involved with this therapy are mostly due to hypervolemia and a 
heavy fluid burden leading to pulmonary edema as well as the edema of the 
brain (Raabe et al., 2005).  
Nimodipine is a calcium channel blocker that is a standard of care for 
patients with aSAH. The dosage recommended is 60 milligrams every 4 hours as 
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a prophylactic measure and administered continuously unless there is good 
indication that vasospasm is not a risk and neurologic status has improved. Many 
studies have shown that nimodipine in aSAH patients reduces the prevalence of 
cerebral infarcts and neurologic deficits. One such study showed that there was a 
34% reduction in cerebral infarcts between patients given a nimodipine regiment 
and patients given a placebo and also a 40% decrease in poor outcomes, such 
as death or severe disability, between those groups (Pickard et al., 1989). The 
mechanism of action that nimodipine takes is still unclear but it remains a 
standard of care for aSAH patients. 
 
Detection of Cerebral Vasospasm 
The purpose of focusing on the detection of cerebral vasospasm onset 
was to predict and prevent the occurrence of neurological deficits associated with 
vasospasm. Clinical assessments of neurological status and consciousness are 
carried out but focal deficits and neurologic deficits are often undetectable, 
especially in poor grade patients, due to coma or sedation (Springborg, 
Frederiksen, Eskesen, & Olsen, 2005). Also this information is not very useful for 
prophylactic measures because ischemia and infarction have already occurred at 
that point.  
The gold standard for detection of cerebral vasospasm in aSAH patients is 
digital subtraction angiography (DSA). DSA can acquire accurate and detailed 
images of the cerebral vasculature and has been shown to be very specific and 
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sensitive in the detection of cerebral vasospasm. However accurate this method 
may be, there are risks that come with DSA. On the one hand, DSA is an 
invasive procedure in which a catheter, placed in the femoral artery, is used and 
is associated with complications such as significant internal bleeding, infection, 
forming an arterioveinous fistula from cannulating the femoral artery and vein, 
femoral artery dissection. Also the contrast dye used in DSA may cause contrast-
induced nephropathy (Orrù, Roccatagliata, Cester, Causin, & Castellan, 2013). 
There has also been shown to be a risk for rebleeding of aneurysms during the 
contrast dye injections for DSA (Saitoh et al., 1995). However, DSA is considered 
to be advantageous because endovascular treatments and therapies may be 
carried out during or immediately after DSA (Wintermark et al., 2006). 
 
Computed Tomography Angiography  
CTA can also be used for the detection of cerebral vasospasm because of 
its ability to reproduce accurate images of the intracranial vasculature (Hsiang, 
Liang, Lam, Zhu, & Poon, 1996; Lenhart et al., 1997). This technique is both less 
expensive and less invasive than digital subtraction angiography (DSA) and has 
been shown to correlate well with results from DSA with respects to cerebral 
vasospasm (Yoon, Choi, Kim, & Cho, 2006). In a study done by Anderson et al., 
it was shown that the detection of cerebral vasospasm in aSAH patients by CTA 
in comparison to DSA had an overall correlation of 86% with a correlation 
coefficient of 0.757 but differed greatly depending on the location of vasospasm 
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and the severity of vasospasm (Anderson, Ashforth, Steinke, & Findlay, 2000). 
This group showed that CTA had a sensitivity ranging from 57% to 100% and a 
sensitivity ranging from 80% to 100%. The reason for the wide range seen in the 
measurement of sensitivity and specificity of this technique to detect vasospasm 
is that it depends on the location of the vasospasm event. CTA seems to be both 
highly sensitive and specific for vasospasm occurring in proximal artery 
segments versus distal artery segments. The same is true for absent vasospasm 
and severe (>50% stenosis) vasospasm while the sensitivity and specificity of 
CTA seems to drop when the vasospasm is mild (<30% stenosis) or moderate 
(30% to 50% stenosis) (Anderson et al.).   
 
Figure 8: CTA and DSA imaging of Vasospasm. CTA and DSA scans of a 51-
year-old woman with aSAH. A: CTA showing aneurysm in the left MCA marked 
by the yellow arrow, B: CTA showing narrowing of artery segments pointed out 
by red arrows, C: DSA confirms both segments of spasm found with CTA (purple 
arrows) (Anderson et al., 2000) 
 
Although CTA is less invasive than DSA and is still comparable in the 
detection of cerebral vasospasm, this technique still uses a contrast dye medium 
to capture images of the cerebral vasculature. This limits the window of 
opportunity for detecting vasospasm as CTA is done sparingly to reduce the 
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chance of contrast nephropathy and also requires the patient to be moved to the 
radiology suite.  
 
Transcranial Doppler Ultrasonography 
Transcranial Doppler ultrasonography (TCD) has become established as a 
non-invasive test for the screening and detection of cerebral vasospasm in aSAH 
patients. TCD can measure the velocity of the blood flow in the cerebral arteries 
and has been shown to give valuable insight into the condition of these arteries. 
TCD operates on the principle that blood flow velocity in an artery is inversely 
proportional to the cross-sectional area of that artery (Rigamonti, Ackery, & 
Baker, 2008).  
Blood flow velocity is measured in cm/s and the defined thresholds for 
vasospasm are as follows: Blood flow velocity below 120 cm/s is considered to 
show no vasospasm, while blood flow velocity above 200 cm/s is considered to 
be highly indicative of vasospasm. Also if the ratio of the blood flow velocity in the 
middle cerebral artery (MCA)/ internal carotid artery (ICA) is >6 it signifies the 
presence of vasospasm and if velocity measurements begin to increase rapidly 
over several days it also signifies vasospasm (Carrera et al., 2009; Lysakowski, 
Walder, Costanza, & Tramèr, 2001).  
Although TCD has become a mainstay in the treatment protocol of aSAH 
as a means for the detection of cerebral vasospasm, the sensitivity and 
specificity in detecting vasospasm has called into question its effectiveness as a 
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screening method. TCD has been shown to have high specificity when compared 
to digital subtraction angiography (DSA) confirmation but moderate to low 
sensitivity (Diringer et al., 2011).  However, other studies have shown that with a 
63% sensitivity and 52% specificity in detecting vasospasm, improvement in 
screening methods is necessary (Carrera et al., 2009).  
The study done by Carrera et al. showed that TCD not only was limited in 
detecting vasospasm but that it was even less predictive of clinical deterioration 
in aSAH patients. With the threshold for vasospasm set at >120 cm/s about 40% 
of patients developed signs of DCI before reaching that threshold and the 
positive predictive value was only 26% (Carrera et al., 2009). The important thing 
to take away from this study though was that 16% of aSAH patients included in 
this study developed signs of DCI but did not reach the >120 cm/s threshold 
(Carrera et al., 2009). 
 
Electroencephalography: EEG 
Electroencephalography (EEG) has been considered as an alternative, 
non-invasive, technique to monitor aSAH patients in the ICU. EEG readings can 
provide continuous measurements of electrical brain activity and has been used 
for many years to monitor for ischemia of the brain in carotid surgery (Jordan, 
2004). The brain is highly oxygen dependent and the electrical activity and 
homeostasis of the brain goes awry in a very short period of time without oxygen. 
Normal cerebral blood flow is quantified as 50-70 mL/100 g/min and an EEG will 
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show abnormalities when cerebral blood flow drops to 30 mL/100 g/min (Astrup, 
Siesjö, & Symon, 1981).  
A few studies have shown that changes in certain EEG parameters such 
as relative alpha variability, alpha-delta ratios, and EEG power are correlated 
with cerebral vasospasm and ensuing DCI (Labar, Fisch, Pedley, Fink, & 
Solomon, 1991; Vespa et al., 1997). In the study done by Vespa et al. all of the 
patients enrolled in the study with angiographic vasospasm confirmation had the 
relative alpha correlate with development and resolution of vasospasm. Also in 
10 out of 19 cases, changes in relative alpha was found at a mean of 2.9 days 
before the diagnosis of cerebral vasospasm (SD 1.73) (Vespa et al., 1997).  
Rathakrishnan et al. showed that mean alpha power was correlated with 
the clinical status and outcome in patients. However, more than focusing on a 
single readout from an EEG that could be used to predict vasospasm and DCI, 
this group concluded that continuous EEG readings could be used as a 
supplement to detection and prediction of outcome.  A review of the data showed 
an improvement in prediction of deterioration and improvement of the patient’s 
condition when EEG was used versus clinical data alone (Rathakrishnan, 
Gotman, Dubeau, & Angle, 2011).  
However, EEG is far from being considered as an alternative or 
replacement for established techniques used in the detection of vasospasm. 
EEG still requires a trained technician and skilled physicians to operate and to 
produce quality readings (Kurtz, Hanafy, & Claassen, 2009). Also, EEG 
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interpretation would be rather infrequent throughout the day and thus poses the 
same obstacles to be overcome as TCD readings. Although the utility of 
quantitative EEG readings has been studied there is a lack of evidence to pursue 
this avenue just yet (Kurtz et al., 2009). 
 
Cerebral Microdialysis 
Microdialysis is a technique for the purpose of sampling and analyzing the 
components of the extracellular fluid in a tissue or organ. It requires a catheter 
that acts as a membrane in which extracellular components can diffuse back and 
forth (Ungerstedt, 1991). This technique can allow for analysis of the extracellular 
environment for days at a time and has recently been proposed and studied as a 
method to monitor cerebral ischemia from vasospasm in patients suffering from 
aSAH (Unterberg, Sakowitz, Sarrafzadeh, Benndorf, & Lanksch, 2001). 
      
Figure 9: Cerebral Microdialysis. (A) Cerebral microdialysis catheter. The 
components are as listed: a) Perfusate pump connector. b) inlet tube. c) 
microdialysis catheter. d) microdialysis membrane. e) outlet tube. f) collecting vial 
and holder. (B) Shows a microdialysis catheter in brain tissue. As isotonic fluid is 
pumped through the catheter, components of the extracellular fluid will equilibrate 
 23 
across the membrane and carried out to be collected and analyzed. (Smith, 
2008) 
 
 Components of the cerebral extracellular fluid that were shown to have 
correlation to clinical status are glutamate, glycerol, lactate, and lactate-pyruvate 
ratio (L:P). In a prospective study, Nilsson et al. showed that an increase in 
lactate and glycerol levels in the cerebral environment was correlated to poor 
clinical status and/or deterioration. They also were able to show that increased 
glutamate levels and an increased L:P ratio also pointed towards poor clinical 
status (Nilsson, Brandt, Ungerstedt, & Säveland, 1999). The utility of measuring 
these extracellular components in aSAH patients was further clarified by 
Sarrafzadeh et al. in another prospective study where it was found that increases 
in lactate and glutamate levels in the cerebral environment was the early marker 
for ischemia while the L:P ratio, glucose, and glycerol levels were indicators of 
already existent ischemia of the brain (Sarrafzadeh et al., 2002).  
Cerebral microdialysis has been shown to be highly sensitive and specific 
in detecting DCI and resulting neurologic damage and has been shown to be 
more specific than TCD or CTA (Sarrafzadeh et al., 2002). The sensitivity has 
been measured to be 94% while the specificity lies around 88% in the prediction 
of DCI (Skjøth-Rasmussen, Schulz, Kristensen, & Bjerre, 2004). Although this 
evidence makes it seem as though cerebral microdialysis is a great alternative 
for the detection of vasospasm and resultant neurological deficit, there are 
inherent flaws and risks involved with this technique.  
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Cerebral microdialysis is an invasive procedure that requires that a 
catheter be inserted into the area of interest and in this case, one that requires 
burr holes. While the use of this technique could be justified for patients with poor 
clinical admission, patients with good initial clinical examinations do not warrant 
such an invasive procedure.  Also, microdialysis can only analyze a localized 
region of extracellular environment (Sarrafzadeh et al., 2002), while cerebral 
vasospasm is a diffuse process making it difficult to determine which region of 
the brain the catheter should be placed in (Hanafy et al., 2010). 
 
Near Infrared Spectroscopy: NIRS 
Near Infrared Spectroscopy (NIRS) is an FDA approved imaging 
technique that can be used to obtain valuable information about cortical 
hemodynamic status. Oxy-hemoglobin and deoxy-hemoglobin have distinct 
absorption spectra and by employing the appropriate wavelengths of light in the 
near infrared spectrum, this technology makes it possible to quantify the changes 
in hemodynamics of the cerebral vasculature (Minati, Kress, Visani, Medford, & 
Critchley, 2011). NIRS passes light through the skull, much like a pulse oximeter, 
and the light will be absorbed and reflected at different wavelengths depending 
on the oxy- and deoxy-hemoglobin content of the arteries (Tichauer, Hadway, 
Lee, St Lawrence, & Lawrence, 2006). Currently NIRS technology is employed in 
carotid endarterectomy surgery to detect cerebral ischemia with a sensitivity and 
specificity of 75% and 77% respectively (Mille et al., 2004) as well as in the ICU 
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to detect seizure activity in adults and neonates (Schachter, Guttag, Schiff, & 
Schomer, 2009; Toet & Lemmers, 2009).  
NIRS has been compared with TCD, EEG, and clinical signs to validate its 
utility in the detection of cerebral ischemia. When NIRS was compared to TCD, 
studies showed that there was a positive relationship between the changes in 
flow velocity of the MCA and changes in regional hemoglobin oxygen saturation 
(rSO2) (Al-Rawi & Kirkpatrick, 2006; Grubhofer et al., 2000). Both of these 
studies concluded that NIRS and TCD both were able to detect patients that 
were at risk for ischemia in carotid endarterectomy but Grubhofer et al. found that 
NIRS had a low specificity for ischemia in their study. 
NIRS as a means of detecting vasospasm was also compared with EEG 
as a means of detecting cerebral ischemia during clamping in carotid 
endarterectomy surgeries (De Letter et al., 1998; Rigamonti et al., 2005). De 
Letter et al. found that when the threshold value for the percentage O2 saturation 
was set at 5% or greater, NIRS had a 100% sensitivity but a 44% specificity in 
the detection of cerebral ischemia in comparison to EEG findings (De Letter et 
al., 1998). Rigamonti et. al set a threshold value at 15% drop in O2 saturation and 
they found that while specificity increased to 82% it came at the expense of a 
drop in sensitivity to 44%. Both studies concluded that NIRS correlated with EEG 
findings in the detection of cerebral ischemia but a threshold value had to be 
determined and the technology had to be calibrated. 
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To date, one group has published a study to assess the utility of NIRS in 
monitoring patients after aSAH for cerebral vasospasm and ischemia in 
comparison to TCD. Yokose et al. studied 14 aSAH patients and 11 age matched 
controls. In this study 6 aSAH patients did not experience anigiographic cerebral 
vasospasm and all six patients had only small changes (<5%) in cerebral oxygen 
saturation (CoSO2). The remaining 8 aSAH patients had larger decreases in 
CoSO2 (>5%) and in this group it was found that 6 patients had confirmed 
angiographic vasospasm while TCD indicated vasospasm in only 4 patients. 
Yokose et al. concluded that NIRS was both sensitive (100%) and specific 
(85.7%) compared to TCD in detecting vasospasm (Yokose et al., 2010). 
 
Objectives 
Aneurysmal subarachnoid hemorrhage affects 30,000 Americans per year 
and continues to have a devastating rate of morbidity and mortality as described 
previously. DCI remains as a notorious complication in aSAH and the focus of 
our study was on the methods of monitoring and detecting cerebral vasospasm in 
aSAH patients. More specifically we proposed to study the utility of using NIRS 
technology in this type of setting and for this purpose.  
Currently, the established screening methods for detecting cerebral 
vasospasm are DSA, CTA, and TCD. As we have outlined above, each of these 
techniques have their own risks and shortcomings. DSA and CTA are both 
invasive procedures that carry risks and also require the use of contrast dye. 
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TCD is non-invasive but has not been shown to have lower specificity and 
sensitivity in detecting vasospasm. All three methods cannot take continuous 
measurements and are thus not as ideal when it comes to detecting cerebral 
vasospasm, which can occur at anytime over a period of many days after 
aneurysmal rupture. TCD is performed once per day and the quality and 
consistency of TCD is highly dependent on the skill of the operator (Bazzocchi, 
Quaia, Zuiani, & Moroldo, 1998). Also the use of contrast dye in angiograms 
limits the number of tests that can be run due to the risk of contrast nephropathy 
(Orrù et al., 2013).  
NIRS however is an FDA approved imaging technique that has been used 
in carotid endarterectomy to monitor for cerebral ischemia. It is a non-invasive 
technique and can take continuous, 24-hour, measurements of cortical 
oxygenation. Additionally, NIRS does not require a trained technician to operate 
and is markedly cheaper than the other methods of detection mentioned here. 
The NIRS cerebral oximetry device (INVOS) from SomaneticsTM also has the 
advantage of being able to utilize 4 different channels to measure different areas 
of the brain since vasospasm is a diffuse process (Somanetics, 2013).  
Our primary hypothesis is that Near Infrared Spectroscopy is a technology 
that can effectively detect cerebral vasospasm after aneurysmal subarachnoid 
hemorrhage in the ICU setting. Our specific aims for this study is as follows: 
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Specific Aim 1: To determine whether NIRS is more specific and sensitive than 
Transcranial Doppler (TCD) at detecting angiogram confirmed vasospasm.  
 
Specific Aim 2: Examine whether NIRS is more responsive to vasospasm 
treatment than TCD in patients that have angiogram-confirmed vasospasm. 
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MATERIALS AND METHODS 
Subject Selection 
The study will be a prospective, case-control, investigator initiated study, 
utilizing patients presenting to the intensive care unit of Beth Israel Deaconess 
Medical Center and healthy volunteers. We plan on recruiting 16 aSAH patients 
who meet the inclusion criteria of 1) having a non-traumatic subarachnoid 
hemorrhage as defined by initial imaging or by the presence of blood and 
xanthochromia in the cerebral spinal fluid and 2) having had symptom onset less 
than 24 hours in duration. Patients must be 18 years or older, must present to 
BIDMC, and informed consent from the subject or their healthcare proxy must be 
obtained within 24 hours of admittance. We also plan on recruiting 16 age- and 
sex-matched healthy volunteers or BIDMC employees that are not under 
supervision of either the Principle Investigator or co-Principle Investigators.  
Patients will be excluded if 1) they expire before 24 hours, 2) on imaging 
have evidence of acute/subacute ischemic stroke, 3) evidence of subdural 
hemorrhage/epidural hemorrhage or 4) meningitis/encephalitis. Patients will also 
be excluded if they have a recent history of trauma. 
 
 
NIRS Measurements 
 
Patients will be consented and enrolled within 24 hours of admittance to 
Beth Israel Deaconess Medical Center and baseline measurements of regional 
oxygen saturation (rSO2) will be taken. The NIRS INVOS® System 
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(SomaneticsTM Corp, Troy, MI) employs a 4-channel system that allows for the 
measurement of rSO2 in 4 different regions. Two of the sensors will be placed on 
the right and left side of the forehead to measure cortical oxygenation while the 
remaining two sensors will be placed on the left and right neck. Care should be 
taken not to place the NIRS sensors over any hair as this would increase the 
chance of inaccurate or faulty readings.  
 
Figure 10: NIRS INVOS® System.  On the left is the NIRS INVOS® System. On 
the right is a picture showing the placement of the NIRS sensors on the patient’s 
left and right forehead (Somanetics, 2013).  
 
The NIRS INVOS® System works by emitting near infrared light photons 
into the brain tissue and quantifying the reflected photons to infer tissue 
oxygenation. There are two different wavelengths of light emitted from the light 
source, which are detected by 2 silicon photodiodes distanced at 3 cm and 4 cm 
away from the light source. By placing 2 light detectors at two different distances 
from the light source, NIRS is able to measure two different depths of 
penetration. By subtracting the near signal from the far signal oxygen saturation 
from just the deeper vasculature is measured (Somanetics, 2013). 
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Patients enrolled in our study will have one hour of NIRS measurements 
taken each day subsequent enrollment and hemodynamic changes will be 
recorded by NIRS for 14 days. The measurements will be taken at approximately 
the same time each day. NIRS measurements will not be used in any way in 
clinical decision-making and will be discontinued if it interferes with the patient’s 
care. 
 
TCD and CTA 
Blood flow velocity measurements were taken by TCD in the ICU once per 
day for 14 days.  
 
Figure 11: Transcranial Doppler. On the left is a display from a standard 
Spencer TCD machine. On the right a technician is performing TCD 
measurements to be interpreted by a physician later (Spencer Technologies, 
2013). 
 
TCD measurements are a standard of care and will be performed by a skilled 
technician. TCD readings showing blood flow velocities of > 120 cm/s will be 
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considered indicative of cerebral vasospasm. CTA imaging will be done on days 
3, 5, and 7 and as deemed necessary by the medical attending.  
 
Data Analysis  
Data analysis will be performed with standard statistical software (SPPSS, 
Inc: Version 12.0, Chicago IL). The Χ2 test or fisher exact test will be used to 
determine the univariate association between DCI and categorical independent 
variables. Categorical grouping will be based on clinical significance or median 
versus mean, depending on normality. Continuous variables will be assessed for 
normality, skewness and kurtosis. Data that is normally distributed will be 
reported with means and standard deviations. Continuous variables will be tested 
using independent sample 2-tail student t test. For non-normally distributed 
variables, the Mann-Whitney U test will be performed. A p value of <0.05 will be 
considered statistically significant. 
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RESULTS 
Patient Profile 
Four patients with aneurysmal subarachnoid hemorrhage were recruited 
into our study during this period of time. Three of the patients were female and 
one patient was male.  3 patients were categorized as Hunt and Hess grade of II 
upon admittance and 1 patient was categorized as Hunt and Hess grade of III. Of 
these 4 patients, 3 patients did not develop clinical signs of cerebral vasospasm 
nor did they develop angiographic vasospasm. One patient developed cerebral 
vasospasm confirmed by CTA and also developed clinical signs of vasospasm.  
Table 1: Patient Profiles  
 Patient 1 Patient 2 Patient 3 Patient 4 
Age 54 62 55 52 
Sex F F M F 
Hunt-Hess II II III II 
Fisher Score III III IV III 
EVD N N Y N 
Location of 
aneurysm 
Perimesence
phalic R PCOM R PICA Basilar Tip 
Angiographic 
vasospasm 
(Y/N) 
N N Y N 
Clinical 
vasospasm 
(Y/N) 
N N Y N 
Table Legend: R, Right; L, Left; PCOM, Posterior Communicating Artery; PICA, 
Posterior Inferior Cerebellar Artery; EVD, External Ventriculostomy Device 
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NIRS  
NIRS measurements were taken within 24 hours of admittance to the 
hospital for one hour and repeated everyday until either the patient was moved to 
the general floor or withdrew from the study voluntarily. Patient 1 had NIRS 
studies done for 6 days, patient 2 for 5 days, patient 3 for 8 days, and patient 4 
for 10 days. Patient 1, 2, and 4 had NIRS studies terminated before the 14th day 
because they were moved out of the ICU to the general floor while the NIRS 
studies for patient 3 was terminated early due to voluntary withdrawal from the 
study.   
Figure 12: Cerebral Vasculature. 
A) Patient 2 had an aneurysm on 
the right posterior communicating 
artery (R PCOM). B) Patient 3 had 
an aneurysm on the right posterior 
inferior cerebellar artery (R PICA). 
C) Patient 4 had an aneurysm on 
the tip of the basilar artery.  
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Each patient had 4 leads measuring rSO2 for both the left and right 
forehead and the left and right neck. The two leads placed on the forehead 
measured rSO2 of the left and right side of the brain while the remaining two 
leads were placed on the left and right side of the neck as controls. %rSO2 was 
recorded by the NIRS machine every 15 minutes yielding 4 measurements per 
hour each day.  
Figure 13: Changes in %rSO2 in each patient.   
 
 
First, the NIRS % rSO2 measurements of the right and left side of each 
patient were plotted to see whether or not there were differences between the 
side of the brain the aneurysm was found and the other side. A paired t-test for 
each patient showed no significant differences between the %rSO2 of the left and 
right side of each patient. 
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Out of the 4 patients enrolled in our study, patient 3 showed both 
angiographic vasospasm and clinical signs of vasospasm on day 8 after aSAH. 
Diffuse vasospasm was found throughout the cerebral vasculature including 
severe vasospasm in the left and right vertebral arteries and basilar artery as well 
as moderate vasospasm in the bilateral Middle Cerebral Artery (MCA) and 
Anterior Cerebral Artery (ACA).  
Figure 14: %rSO2 Differences in Patients without Vasospasm versus 
Patients with Vasospasm 
 
 
As seen in Figure 14, NIRS measurements taken at 15-minute intervals for an 
hour each day shows that the average % rSO2 of controls were significantly 
lower on the left side (p<0.0001) and right side (p = 0.0004) than the % rSO2 of 
patient 3, who had vasospasm. The mean of differences for the left side of the 
brain in controls versus patient 3 was 10.58 and the mean of differences for the 
right side of the brain in controls versus patient 3 was 8.37.  
 
NIRS versus TCD 
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A non-dimensional index for NIRS measurements was created in which 
the formula rSO2(neck)/rSO2(cerebral) was used. A NIRS index value of 1 would 
indicate normal oxygen saturation while a decrease in the NIRS index value was 
considered to be an indication of possible cerebral vasospasm indicating % 
cerebral rSO2 increased without a change in neck rSO2. This is due to the fact 
that compensatory hyperemia of the vasospastic artery was expected, and 
therefore more blood flow in the initial phase vasospasm when cerebral 
autoregulation is intact.  Consequently, this is why we see increased blood flow 
velocities in TCD with vasospasm; it is due to cerebral autoregulation and the 
need to compensate for decreased perfusion pressures.   
A non-dimensional TCD index using the formula TCDR/TCDL was also 
created. An increasing trend of TCD index would indicate vasospasm. After 
looking through the patient data, it was decided to use the TCD measurements 
from the left side of the brain as the control for the TCD measurements from the 
right due to the fact that most aneurysms were found on the right side of the 
brain.  
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Figure 15: NIRS Index and TCD Index 
 
 
The NIRS index and the TCD index for each patient was graphed. The NIRS 
index for each patient showed that there were no significant difference between 
the left and right sides and no decreasing trends in the NIRS index that would 
indicate vasospasm. However, in patients 1 and 4, who did not have 
angiographic or clinical vasospasm, TCD index showed a flat or decreasing trend 
in the TCD index. Interestingly, an increasing trend in the TCD index of patient 3, 
who had both clinical and angiographic vasospasm, was found.   
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DISCUSSION 
This study set out to determine the utility of NIRS in the detection of 
cerebral vasospasm in aSAH patients. Four patients were enrolled that 
presented to Beth Israel Deaconess Medical Center (BIDMC) with aSAH and 
performed NIRS studies on each patient for a maximum of 14 days or until either 
the patient was moved out of the ICU or voluntarily withdrawn from the study. 
With the small number of patients that were enrolled into this study it was difficult 
to carry out any significant statistical analysis but the preliminary data we were 
able to gather gave some interesting insights. Patient 1 had a perimesencephalic 
non-aneurysmal subarachnoid hemorrhage but we decided that this subject 
could serve as a control for the aSAH patients at this preliminary stage because 
of the benign course that this specific bleed takes. Perimesencephalic 
hemorrhages are not associated with intracerebral hemorrhage or intraventricular 
hemorrhage and these patients generally have good outcomes (J van Gijn, Van 
Dongen, Vermeulen, & Hijdra, 1985). Age matched controls were not recruited 
for the study yet and recruitment of additional patients for the aSAH group was 
the first priority.   
The NIRS INVOS® System employs a 4-channel monitoring system 
allowing for rSO2 measurements of 4 different areas. In our study both the left 
and right side of the forehead were measured allowing any changes in rSO2 
between the two sides of the brains to be observed. The measurements of rSO2 
were compared between the left and right sides of the brain for each patient and 
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no significant differences were found in the mean rSO2 measurements between 
the sides in each patient. Patient 3 was the only patient who had angiographic 
vasospasm and clinical vasospasm but due to the family withdrawing the patient 
from the study, measurements at every time point could not be collected and 
therefore the conclusion that there were not any differences in regional oxygen 
saturation between the two sides of the brain could not be made.  
The rSO2 measurements taken each day between the patients who had 
experienced vasospasm versus patients who did not experience vasospasm 
were compared. Patient 3’s rSO2 was compared to the average rSO2 
measurements of the other 3 patients at each time point and a significant 
difference between the mean rSO2 between patient 3 with vasospasm and the 
other 3 patients without vasospasm on both the left (p<0.0001) and right (p = 
0.0004) side of the brain was found. It was observed that patient 3 had a mean 
difference of 10.58% higher rSO2 on the left side and 8.37% higher on the right 
side than the averages of the 3 patients that did not experience vasospasm at 
each time point.  
It was determined that increasing trends in %rSO2 may serve as an 
indication for cerebral vasospasm based on a recent study by Rose et al. 
analyzing brain tissue oxygenation and its correlation to cerebral blood flow and 
cerebral perfusion pressure along with other phyisiological parameters. Cerebral 
autoregulation maintains constant cerebral blood flow over a range of systemic 
blood pressure but in aSAH patients with vasospasm the cerebral arteries 
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behave in a way such that it restricts cerebral perfusion (Rose, Neill, & Hemphill, 
2006). Since the multiple studies analyzed by Rose et al. show that brain oxygen 
tension are directly correlated with mean arterial pressure and cerebral perfusion 
pressure, it can be concluded that a lack of cerebral perfusion caused by 
cerebral vasospasm would lead to an increase in systemic blood pressure to 
compensate. This would show an increase in oxy-hemoglobin passing through a 
given segment of artery at any time leading to an increased %rSO2 output by 
NIRS. 
Due to the fact that this was a validation study for the NIRS technology, 
there was no definitive threshold for an increase in %rSO2 to define the 
occurrence of vasospasm. In order to gather preliminary data on the correlation 
between the NIRS measurements and the TCD measurements, a non-
dimensional index for both the NIRS readings and TCD readings was created. 
The NIRS index number was calculated for each time point by dividing the neck 
(control) rSO2 measurement by the forehead rSO2 measurements. A decreasing 
trend in the NIRS index number would indicate an increase in oxygen carrying 
capacity secondary to increased blood velocities and concomitant vasospasm. 
As previously explained, a TCD index was created as well using the formula 
TCDR /TCDL because we had found that patients 2 and 3 had aneurysms on their 
right side while patient 4 had an aneurysm at the midline. The left side of the 
brain served as a control for the right side in this case and an increasing trend in 
the TCD index would suggest vasospasm. 
 42 
In all 4 patients a flat trend for the NIRS index was observed. Patient 3, 
who had vasospasm, did not have the expected decreasing trend but the 3 other 
patients had a flat trend, which was consistent with the absence of vasospasm. 
Using this parameter, NIRS was unable to detect the presence of vasospasm in 
patient 3 through the NIRS index. However, the NIRS index showed that it 
correctly predicted that the other 3 patients did not develop vasospasm.  
The TCD index showed some interesting results. For patient 3 
(vasospasm positive) the TCD index showed an increasing trend while for patient 
1 and 4 (vasospasm negative) the TCD index showed a flat trend and a 
decreasing trend respectively. A TCD index for patient 2 could not be created 
because there was too little information from the TCD reports. Poor bone window 
did not allow for TCD readings in many of the different arteries that were 
insonated.  
In conclusion, there was a lack of patient recruitment both in number and 
in the types of patients that fit our recruitment criteria. By comparing the average 
absolute rSO2 measurements in controls (patients without vasospasm) at each 
time point to the rSO2 measurements of patient 3 (patient with vasospasm) it was 
found that patient 3 had significantly higher rSO2 in the brain indicating that NIRS 
was successful in detecting vasospasm in this case. The NIRS index was unable 
to detect vasospasm for patient 3 but did not give any false positives in the 3 
patients without vasospasm. The TCD index showed an increasing trend in 
patient 3 (with vasospasm) and in patients 1 and 4 showed a flat and decreasing 
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trend. Through this interim assessment a definitive conclusion could not be 
reached about the utility of NIRS in the detection of vasospasm in aSAH patients, 
however because only one patient had angiographic and clinical vasospasm, 
NIRS may still prove to be a useful tool for detecting vasospasm 24 hours a day 
in the ICU. TCD remains a useful tool in the detection of vasospasm, but still has 
its own limitations due to the fact that insonation of each artery is a task which 
requires a high level of expertise and may even be thwarted by poor bone 
window to visualize blood flow velocity. Further recruitment of patients and aged 
matched controls are necessary for this study. 
 
 44 
LIST of JOURNAL ABBREVIATIONS  
 
AJNR   American Journal of Neuroradiology 
AJR   American Journal of Roentgenology 
BMJ   British Medical Journal 
E&B   Epilepsy & Behavior  
 
 45 
REFERENCES 
Al-Rawi, P. G., & Kirkpatrick, P. J. (2006). Tissue oxygen index: thresholds for 
cerebral ischemia using near-infrared spectroscopy. Stroke; a journal of 
cerebral circulation, 37(11), 2720–2725. 
doi:10.1161/01.STR.0000244807.99073.ae 
Alberico, R. A., Patel, M., Casey, S., Jacobs, B., Maguire, W., & Decker, R. 
(1995). Evaluation of the circle of Willis with three-dimensional CT 
angiography in patients with suspected intracranial aneurysms. AJNR. 
American journal of neuroradiology, 16(8), 1571–1578; discussion 1579–
1580. 
Anderson, G. B., Ashforth, R., Steinke, D. E., & Findlay, J. M. (2000). CT 
angiography for the detection of cerebral vasospasm in patients with acute 
subarachnoid hemorrhage. AJNR. American journal of neuroradiology, 
21(6), 1011–1015. 
Astrup, J., Siesjö, B. K., & Symon, L. (1981). Thresholds in cerebral ischemia - 
the ischemic penumbra. Stroke; a journal of cerebral circulation, 12(6), 
723–725. 
Atlas, S. W. (1997). Magnetic resonance imaging of intracranial aneurysms. 
Neuroimaging clinics of North America, 7(4), 709–720. 
Awad, I. A., Carter, L. P., Spetzler, R. F., Medina, M., & Williams, F. C. (1987). 
Clinical vasospasm after subarachnoid hemorrhage: response to 
 46 
hypervolemic hemodilution and arterial hypertension. Stroke, 18(2), 365–
372. doi:10.1161/01.STR.18.2.365 
Bazzocchi, M., Quaia, E., Zuiani, C., & Moroldo, M. (1998). Transcranial Doppler: 
state of the art. European journal of radiology, 27 Suppl 2, S141–148. 
Bederson, J. B., Connolly, E. S., Batjer, H. H., Dacey, R. G., Dion, J. E., Diringer, 
M. N., … Rosenwasser, R. H. (2009a). Guidelines for the Management of 
Aneurysmal Subarachnoid Hemorrhage A Statement for Healthcare 
Professionals From a Special Writing Group of the Stroke Council, 
American Heart Association. Stroke, 40(3), 994–1025. 
doi:10.1161/STROKEAHA.108.191395 
Bederson, J. B., Connolly, E. S., Batjer, H. H., Dacey, R. G., Dion, J. E., Diringer, 
M. N., … Rosenwasser, R. H. (2009b). Guidelines for the Management of 
Aneurysmal Subarachnoid Hemorrhage A Statement for Healthcare 
Professionals From a Special Writing Group of the Stroke Council, 
American Heart Association. Stroke, 40(3), 994–1025. 
doi:10.1161/STROKEAHA.108.191395 
Carrera, E., Schmidt, J. M., Oddo, M., Fernandez, L., Claassen, J., Seder, D., … 
Mayer, S. A. (2009). Transcranial Doppler for predicting delayed cerebral 
ischemia after subarachnoid hemorrhage. Neurosurgery, 65(2), 316–323; 
discussion 323–324. doi:10.1227/01.NEU.0000349209.69973.88 
Darby, J. M., Yonas, H., Marks, E. C., Durham, S., Snyder, R. W., & Nemoto, E. 
M. (1994). Acute cerebral blood flow response to dopamine-induced 
 47 
hypertension after subarachnoid hemorrhage. Journal of neurosurgery, 
80(5), 857–864. doi:10.3171/jns.1994.80.5.0857 
De Letter, J. A., Sie, H. T., Thomas, B. M., Moll, F. L., Algra, A., Eikelboom, B. 
C., & Ackerstaff, R. G. (1998). Near-infrared reflected spectroscopy and 
electroencephalography during carotid endarterectomy--in search of a 
new shunt criterion. Neurological research, 20 Suppl 1, S23–27. 
Diringer, M. N., Bleck, T. P., Claude Hemphill, J., 3rd, Menon, D., Shutter, L., 
Vespa, P., … Zipfel, G. (2011). Critical care management of patients 
following aneurysmal subarachnoid hemorrhage: recommendations from 
the Neurocritical Care Society’s Multidisciplinary Consensus Conference. 
Neurocritical care, 15(2), 211–240. doi:10.1007/s12028-011-9605-9 
Dupont, S. A., Wijdicks, E. F. M., Lanzino, G., & Rabinstein, A. A. (2010). 
Aneurysmal subarachnoid hemorrhage: an overview for the practicing 
neurologist. Seminars in neurology, 30(5), 545–554. doi:10.1055/s-0030-
1268862 
Dupont, S. A., Wijdicks, E. F. M., Manno, E. M., & Rabinstein, A. A. (2008). 
Thunderclap headache and normal computed tomographic results: value 
of cerebrospinal fluid analysis. Mayo Clinic proceedings. Mayo Clinic, 
83(12), 1326–1331. doi:10.1016/S0025-6196(11)60780-5 
Edlow, J. A. (2005). Diagnosis of subarachnoid hemorrhage. Neurocritical Care, 
2(2), 99–109. doi:10.1385/NCC:2:2:099 
 48 
Ekelund, A., Reinstrup, P., Ryding, E., Andersson, A.-M., Molund, T., 
Kristiansson, K.-A., … Säveland, H. (2002). Effects of iso- and 
hypervolemic hemodilution on regional cerebral blood flow and oxygen 
delivery for patients with vasospasm after aneurysmal subarachnoid 
hemorrhage. Acta neurochirurgica, 144(7), 703–712; discussion 712–713. 
doi:10.1007/s00701-002-0959-9 
Fisher, C. M., Kistler, J. P., & Davis, J. M. (1980). Relation of cerebral 
vasospasm to subarachnoid hemorrhage visualized by computerized 
tomographic scanning. Neurosurgery, 6(1), 1–9. 
Froehler, M. T. (2013). Endovascular treatment of ruptured intracranial 
aneurysms. Current neurology and neuroscience reports, 13(2), 326. 
doi:10.1007/s11910-012-0326-z 
Frontera, J. A., Fernandez, A., Schmidt, J. M., Claassen, J., Wartenberg, K. E., 
Badjatia, N., … Mayer, S. A. (2009). Defining vasospasm after 
subarachnoid hemorrhage: what is the most clinically relevant definition? 
Stroke; a journal of cerebral circulation, 40(6), 1963–1968. 
doi:10.1161/STROKEAHA.108.544700 
Grubhofer, G., Plöchl, W., Skolka, M., Czerny, M., Ehrlich, M., & Lassnigg, A. 
(2000). Comparing Doppler ultrasonography and cerebral oximetry as 
indicators for shunting in carotid endarterectomy. Anesthesia and 
analgesia, 91(6), 1339–1344. 
 49 
Hanafy, K. A., Morgan Stuart, R., Fernandez, L., Schmidt, J. M., Claassen, J., 
Lee, K., … Badjatia, N. (2010). Cerebral inflammatory response and 
predictors of admission clinical grade after aneurysmal subarachnoid 
hemorrhage. Journal of clinical neuroscience: official journal of the 
Neurosurgical Society of Australasia, 17(1), 22–25. 
doi:10.1016/j.jocn.2009.09.003 
Hauerberg, J., Andersen, B. B., Eskesen, V., Rosenørn, J., & Schmidt, K. (1991). 
Importance of the recognition of a warning leak as a sign of a ruptured 
intracranial aneurysm. Acta neurologica Scandinavica, 83(1), 61–64. 
Hijdra, A., Van Gijn, J., Stefanko, S., Van Dongen, K. J., Vermeulen, M., & Van 
Crevel, H. (1986). Delayed cerebral ischemia after aneurysmal 
subarachnoid hemorrhage: clinicoanatomic correlations. Neurology, 36(3), 
329–333. 
Hsiang, J. N., Liang, E. Y., Lam, J. M., Zhu, X. L., & Poon, W. S. (1996). The role 
of computed tomographic angiography in the diagnosis of intracranial 
aneurysms and emergent aneurysm clipping. Neurosurgery, 38(3), 481–
487 discussion 487. 
Huang, J., & Van Gelder, J. M. (2002). The probability of sudden death from 
rupture of intracranial aneurysms: a meta-analysis. Neurosurgery, 51(5), 
1101–1105; discussion 1105–1107. 
Huston, J., 3rd, Nichols, D. A., Luetmer, P. H., Goodwin, J. T., Meyer, F. B., 
Wiebers, D. O., & Weaver, A. L. (1994). Blinded prospective evaluation of 
 50 
sensitivity of MR angiography to known intracranial aneurysms: 
importance of aneurysm size. AJNR. American journal of neuroradiology, 
15(9), 1607–1614. 
Jordan, K. G. (2004). Emergency EEG and continuous EEG monitoring in acute 
ischemic stroke. Journal of clinical neurophysiology: official publication of 
the American Electroencephalographic Society, 21(5), 341–352. 
Kaufmann, T. J., Huston, J., 3rd, Mandrekar, J. N., Schleck, C. D., Thielen, K. R., 
& Kallmes, D. F. (2007). Complications of diagnostic cerebral 
angiography: evaluation of 19,826 consecutive patients. Radiology, 
243(3), 812–819. doi:10.1148/radiol.2433060536 
Korja, M., Silventoinen, K., Laatikainen, T., Jousilahti, P., Salomaa, V., & Kaprio, 
J. (2013). Cause-specific mortality of 1-year survivors of subarachnoid 
hemorrhage. Neurology, 80(5), 481–486. 
doi:10.1212/WNL.0b013e31827f0fb5 
Korogi, Y., Takahashi, M., Katada, K., Ogura, Y., Hasuo, K., Ochi, M., … Imakita, 
S. (1999). Intracranial aneurysms: detection with three-dimensional CT 
angiography with volume rendering--comparison with conventional 
angiographic and surgical findings. Radiology, 211(2), 497–506. 
Kuma, V., Abbas, A. K., Fausto, N., & Mitchell, R. (2007). Robbins Basic 
Pathology, Eighth Edition (8th ed.). Saunders/Elsevier. 
 51 
Kurtz, P., Hanafy, K. A., & Claassen, J. (2009). Continuous EEG monitoring: is it 
ready for prime time? Current opinion in critical care, 15(2), 99–109. 
doi:10.1097/MCC.0b013e3283294947 
Labar, D. R., Fisch, B. J., Pedley, T. A., Fink, M. E., & Solomon, R. A. (1991). 
Quantitative EEG monitoring for patients with subarachnoid hemorrhage. 
Electroencephalography and clinical neurophysiology, 78(5), 325–332. 
Lenhart, M., Bretschneider, T., Gmeinwieser, J., Ullrich, O. W., Schlaier, J., & 
Feuerbach, S. (1997). Cerebral CT angiography in the diagnosis of acute 
subarachnoid hemorrhage. Acta radiologica (Stockholm, Sweden: 1987), 
38(5), 791–796. 
Linn, F. H. H., Rinkel, G. J. E., Algra, A., & Gijn, J. van. (1996). Incidence of 
Subarachnoid Hemorrhage Role of Region, Year, and Rate of Computed 
Tomography: A Meta-Analysis. Stroke, 27(4), 625–629. 
doi:10.1161/01.STR.27.4.625 
Lysakowski, C., Walder, B., Costanza, M. C., & Tramèr, M. R. (2001). 
Transcranial Doppler versus angiography in patients with vasospasm due 
to a ruptured cerebral aneurysm: A systematic review. Stroke; a journal of 
cerebral circulation, 32(10), 2292–2298. 
Mille, T., Tachimiri, M. E., Klersy, C., Ticozzelli, G., Bellinzona, G., Blangetti, I., 
… Odero, A. (2004). Near infrared spectroscopy monitoring during carotid 
endarterectomy: which threshold value is critical? European journal of 
vascular and endovascular surgery: the official journal of the European 
 52 
Society for Vascular Surgery, 27(6), 646–650. 
doi:10.1016/j.ejvs.2004.02.012 
Minati, L., Kress, I. U., Visani, E., Medford, N., & Critchley, H. D. (2011). Intra- 
and extra-cranial effects of transient blood pressure changes on brain 
near-infrared spectroscopy (NIRS) measurements. Journal of 
neuroscience methods, 197(2), 283–288. 
doi:10.1016/j.jneumeth.2011.02.029 
Molyneux, A., Kerr, R., Stratton, I., Sandercock, P., Clarke, M., Shrimpton, J., & 
Holman, R. (2002). International Subarachnoid Aneurysm Trial (ISAT) of 
neurosurgical clipping versus endovascular coiling in 2143 patients with 
ruptured intracranial aneurysms: a randomised trial. Lancet, 360(9342), 
1267–1274. 
Nilsson, O. G., Brandt, L., Ungerstedt, U., & Säveland, H. (1999). Bedside 
detection of brain ischemia using intracerebral microdialysis: subarachnoid 
hemorrhage and delayed ischemic deterioration. Neurosurgery, 45(5), 
1176–1184; discussion 1184–1185. 
Orrù, E., Roccatagliata, L., Cester, G., Causin, F., & Castellan, L. (2013). 
Complications of endovascular treatment of cerebral aneurysms. 
European journal of radiology. doi:10.1016/j.ejrad.2012.12.011 
Pickard, J. D., Murray, G. D., Illingworth, R., Shaw, M. D., Teasdale, G. M., Foy, 
P. M., … Richards, P. (1989). Effect of oral nimodipine on cerebral 
 53 
infarction and outcome after subarachnoid haemorrhage: British aneurysm 
nimodipine trial. BMJ (Clinical research ed.), 298(6674), 636–642. 
Raabe, A., Beck, J., Keller, M., Vatter, H., Zimmermann, M., & Seifert, V. (2005). 
Relative importance of hypertension compared with hypervolemia for 
increasing cerebral oxygenation in patients with cerebral vasospasm after 
subarachnoid hemorrhage. Journal of neurosurgery, 103(6), 974–981. 
doi:10.3171/jns.2005.103.6.0974 
Rabinstein, A. A. (2013). Subarachnoid hemorrhage. Neurology, 80(5), e56–59. 
doi:10.1212/WNL.0b013e3182834b22 
Rabinstein, A. A., Friedman, J. A., Weigand, S. D., McClelland, R. L., Fulgham, 
J. R., Manno, E. M., … Wijdicks, E. F. M. (2004). Predictors of cerebral 
infarction in aneurysmal subarachnoid hemorrhage. Stroke; a journal of 
cerebral circulation, 35(8), 1862–1866. 
doi:10.1161/01.STR.0000133132.76983.8e 
Rathakrishnan, R., Gotman, J., Dubeau, F., & Angle, M. (2011). Using 
continuous electroencephalography in the management of delayed 
cerebral ischemia following subarachnoid hemorrhage. Neurocritical care, 
14(2), 152–161. doi:10.1007/s12028-010-9495-2 
Rigamonti, A., Ackery, A., & Baker, A. J. (2008). Transcranial Doppler monitoring 
in subarachnoid hemorrhage: a critical tool in critical care. Canadian 
journal of anaesthesia = Journal canadien d’anesthésie, 55(2), 112–123. 
doi:10.1007/BF03016323 
 54 
Rigamonti, A., Scandroglio, M., Minicucci, F., Magrin, S., Carozzo, A., & Casati, 
A. (2005). A clinical evaluation of near-infrared cerebral oximetry in the 
awake patient to monitor cerebral perfusion during carotid 
endarterectomy. Journal of clinical anesthesia, 17(6), 426–430. 
doi:10.1016/j.jclinane.2004.09.007 
Ronne-Engström, E., Enblad, P., & Lundström, E. (2013). Health-related quality 
of life at median 12 months after aneurysmal subarachnoid hemorrhage, 
measured with EuroQoL-5D. Acta neurochirurgica. doi:10.1007/s00701-
012-1612-x 
Roos, Y. B., De Haan, R. J., Beenen, L. F., Groen, R. J., Albrecht, K. W., & 
Vermeulen, M. (2000). Complications and outcome in patients with 
aneurysmal subarachnoid haemorrhage: a prospective hospital based 
cohort study in the Netherlands. Journal of neurology, neurosurgery, and 
psychiatry, 68(3), 337–341. 
Rose, J. C., Neill, T. A., & Hemphill, J. C., 3rd. (2006). Continuous monitoring of 
the microcirculation in neurocritical care: an update on brain tissue 
oxygenation. Current opinion in critical care, 12(2), 97–102. 
doi:10.1097/01.ccx.0000216574.26686.e9 
Rosen, D. S., & Macdonald, R. L. (2005). Subarachnoid hemorrhage grading 
scales: a systematic review. Neurocritical care, 2(2), 110–118. 
doi:10.1385/NCC:2:2:110 
 55 
Saitoh, H., Hayakawa, K., Nishimura, K., Okuno, Y., Teraura, T., Yumitori, K., & 
Okumura, A. (1995). Rerupture of cerebral aneurysms during 
angiography. AJNR. American journal of neuroradiology, 16(3), 539–542. 
Sarrafzadeh, A. S., Sakowitz, O. W., Kiening, K. L., Benndorf, G., Lanksch, W. 
R., & Unterberg, A. W. (2002). Bedside microdialysis: a tool to monitor 
cerebral metabolism in subarachnoid hemorrhage patients? Critical care 
medicine, 30(5), 1062–1070. 
Schachter, S. C., Guttag, J., Schiff, S. J., & Schomer, D. L. (2009). Advances in 
the application of technology to epilepsy: the CIMIT/NIO Epilepsy 
Innovation Summit. Epilepsy & behavior: E&B, 16(1), 3–46. 
Skjøth-Rasmussen, J., Schulz, M., Kristensen, S. R., & Bjerre, P. (2004). 
Delayed neurological deficits detected by an ischemic pattern in the 
extracellular cerebral metabolites in patients with aneurysmal 
subarachnoid hemorrhage. Journal of neurosurgery, 100(1), 8–15. 
doi:10.3171/jns.2004.100.1.0008 
Smith, M. (2008). Perioperative Uses of Transcranial Perfusion Monitoring. 
Neurosurgery Clinics of North America, 19(3), 489–502. 
doi:10.1016/j.nec.2008.07.008 
Somanetics. (2013). INVOS® System by Specialty. March 13, 2013. 
http://www.somanetics.com/invos-system 
Spencer Technologies. (2013). Products. March 13, 2013. 
http://spencertechnologies.com/products.html 
 56 
Springborg, J. B., Frederiksen, H.-J., Eskesen, V., & Olsen, N. V. (2005). Trends 
in monitoring patients with aneurysmal subarachnoid haemorrhage. British 
journal of anaesthesia, 94(3), 259–270. doi:10.1093/bja/aei004 
Taylor, T. N., Davis, P. H., Torner, J. C., Holmes, J., Meyer, J. W., & Jacobson, 
M. F. (1996). Lifetime Cost of Stroke in the United States. Stroke, 27(9), 
1459–1466. doi:10.1161/01.STR.27.9.1459 
Tichauer, K. M., Hadway, J. A., Lee, T.-Y., St Lawrence, K., & Lawrence, K. S. 
(2006). Measurement of cerebral oxidative metabolism with near-infrared 
spectroscopy: a validation study. Journal of cerebral blood flow and 
metabolism: official journal of the International Society of Cerebral Blood 
Flow and Metabolism, 26(5), 722–730. doi:10.1038/sj.jcbfm.9600230 
Tjahjadi, M., Heinen, C., König, R., Rickels, E., Wirtz, C. R., Woischneck, D., & 
Kapapa, T. (2012). Health-Related Quality of Life After Spontaneous 
Subarachnoid Hemorrhage Measured in a Recent Patient Population. 
World neurosurgery. doi:10.1016/j.wneu.2012.10.009 
Toet, M. C., & Lemmers, P. M. A. (2009). Brain monitoring in neonates. Early 
human development, 85(2), 77–84. doi:10.1016/j.earlhumdev.2008.11.007 
Ungerstedt, U. (1991). Microdialysis--principles and applications for studies in 
animals and man. Journal of internal medicine, 230(4), 365–373. 
University of Iowa. (n.d.). Giant Left MCA Aneurysm. March 12, 2013. 
http://www.uiowa.edu/~c064s01/nr067.htm 
 57 
University of Maryland Medical Center. (2009). Lumbar Puncture. March 13, 
2013. http://www.umm.edu/imagepages/9587.htm 
Unterberg, A. W., Sakowitz, O. W., Sarrafzadeh, A. S., Benndorf, G., & Lanksch, 
W. R. (2001). Role of bedside microdialysis in the diagnosis of cerebral 
vasospasm following aneurysmal subarachnoid hemorrhage. Journal of 
neurosurgery, 94(5), 740–749. doi:10.3171/jns.2001.94.5.0740 
Van Gijn, J, & Van Dongen, K. J. (1982). The time course of aneurysmal 
haemorrhage on computed tomograms. Neuroradiology, 23(3), 153–156. 
Van Gijn, J, Van Dongen, K. J., Vermeulen, M., & Hijdra, A. (1985). 
Perimesencephalic hemorrhage: a nonaneurysmal and benign form of 
subarachnoid hemorrhage. Neurology, 35(4), 493–497. 
Van Gijn, Jan, Kerr, R. S., & Rinkel, G. J. Subarachnoid haemorrhage. The 
Lancet, 369(9558), 306–318. doi:10.1016/S0140-6736(07)60153-6 
Vergouwen, M. D. I., Vermeulen, M., Van Gijn, J., Rinkel, G. J. E., Wijdicks, E. 
F., Muizelaar, J. P., … Roos, Y. B. W. E. M. (2010). Definition of delayed 
cerebral ischemia after aneurysmal subarachnoid hemorrhage as an 
outcome event in clinical trials and observational studies: proposal of a 
multidisciplinary research group. Stroke; a journal of cerebral circulation, 
41(10), 2391–2395. doi:10.1161/STROKEAHA.110.589275 
Vermeulen, M., & Van Gijn, J. (1990). The diagnosis of subarachnoid 
haemorrhage. Journal of neurology, neurosurgery, and psychiatry, 53(5), 
365–372. 
 58 
Vespa, P. M., Nuwer, M. R., Juhász, C., Alexander, M., Nenov, V., Martin, N., & 
Becker, D. P. (1997). Early detection of vasospasm after acute 
subarachnoid hemorrhage using continuous EEG ICU monitoring. 
Electroencephalography and clinical neurophysiology, 103(6), 607–615. 
Vieco, P. T., Shuman, W. P., Alsofrom, G. F., & Gross, C. E. (1995). Detection of 
circle of Willis aneurysms in patients with acute subarachnoid 
hemorrhage: a comparison of CT angiography and digital subtraction 
angiography. AJR. American journal of roentgenology, 165(2), 425–430. 
Vlak, M. H. M., Rinkel, G. J. E., Greebe, P., Greving, J. P., & Algra, A. (2013). 
Lifetime risks for aneurysmal subarachnoid haemorrhage: multivariable 
risk stratification. Journal of neurology, neurosurgery, and psychiatry. 
doi:10.1136/jnnp-2012-303783 
Von Vogelsang, A.-C., Wengström, Y., Svensson, M., & Forsberg, C. (2012). 
Descriptive Epidemiology in Relation to Gender Differences and 
Treatment Modalities 10 Years After Intracranial Aneurysm Rupture in the 
Stockholm Cohort 1996-1999. World neurosurgery. 
doi:10.1016/j.wneu.2012.06.041 
Wilcock, D., Jaspan, T., Holland, I., Cherryman, G., & Worthington, B. (1996). 
Comparison of magnetic resonance angiography with conventional 
angiography in the detection of intracranial aneurysms in patients 
presenting with subarachnoid haemorrhage. Clinical radiology, 51(5), 
330–334. 
 59 
Williams, A. (2004). Xanthochromia in the cerebrospinal fluid. Practical 
Neurology, 4, 174–175. 
Wintermark, M., Ko, N. U., Smith, W. S., Liu, S., Higashida, R. T., & Dillon, W. P. 
(2006). Vasospasm after subarachnoid hemorrhage: utility of perfusion CT 
and CT angiography on diagnosis and management. AJNR. American 
journal of neuroradiology, 27(1), 26–34. 
Yale Medical Group. (n.d.). Cerebral Aneurysm. March 14, 2013. 
http://www.yalemedicalgroup.org/stw/Page.asp?PageID=STW025719  
Yokose, N., Sakatani, K., Murata, Y., Awano, T., Igarashi, T., Nakamura, S., … 
Katayama, Y. (2010). Bedside monitoring of cerebral blood oxygenation 
and hemodynamics after aneurysmal subarachnoid hemorrhage by 
quantitative time-resolved near-infrared spectroscopy. World 
neurosurgery, 73(5), 508–513. doi:10.1016/j.wneu.2010.02.061 
Yoon, D. Y., Choi, C. S., Kim, K. H., & Cho, B.-M. (2006). Multidetector-row CT 
angiography of cerebral vasospasm after aneurysmal subarachnoid 
hemorrhage: comparison of volume-rendered images and digital 
subtraction angiography. AJNR. American journal of neuroradiology, 
27(2), 370–377. 
 
 Curriculum Vitae 
 
 
 
 
 
                  
 
 
                                                                                                 
 
 
 
                                                                                                              
  
 
 
 
 
  
        
 
 
  
  
 
 
  
                        
 
 
 
  
 
   
  
   
 
 
  
               
 
     
  
  
   
 
 
                       
 
 
 
  
 
  
  
  
 
 
 
 
 
  
                               
 
 
 
  
  
     
 
   
   
 
 
 
   
  
 
  
 
 
  
                                                                                              
 
 
 
    
  
  
 
 
 
               
   
 
 
    
  
  
   
  
  
 
  
            
 
 
 
  
 
 
